Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Marchetti

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
TH Open : Companion Journal to Thrombosis and Haemostasis|February 15, 2021
Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease RecurrencePatricia Gomez-Rosas, Marina Pesenti, Cristina Verzeroli, et al.
Cancers|September 23, 2022
Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal CancerCinzia Giaccherini, Cristina Verzeroli, Laura Russo, et al.
Breast Cancer Research and Treatment|September 15, 2016
Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2Irene Catucci, Silvia Casadei, Yuan Chun Ding, et al.
Haematologica|September 28, 2019
Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancerCinzia Giaccherini, Marina Marchetti, Giovanna Masci, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 22, 2014
PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of BergamoIrene Catucci, Paolo Peterlongo, Sara Ciceri, et al.
Journal of Thrombosis and Haemostasis : JTH|March 8, 2025
Activated factor XI-antithrombin and thrombin-antithrombin complexes in the prediction of venous thromboembolism and mortality in patients with non-small-cell lung cancerPatricia Gomez-Rosas, Magdolna Nagy, Henry M H Spronk, et al.
Journal of Thrombosis and Haemostasis : JTH|April 13, 2023
Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohortCristina Verzeroli, Cinzia Giaccherini, Laura Russo, et al.
Cancers|September 28, 2023
A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer PatientsPatricia Gomez-Rosas, Cinzia Giaccherini, Laura Russo, et al.
Hemasphere|August 29, 2025
Prevention and treatment of venous thromboembolism in patients with multiple myeloma: Clinical practice guidelines on behalf of the European Myeloma NetworkGrigoris Gerotziafas, Despina Fotiou, Inger Nijhof, et al.
Journal of Thrombosis and Haemostasis : JTH|May 13, 2020
Thrombin generation predicts early recurrence in breast cancer patientsMarina Marchetti, Cinzia Giaccherini, Giovanna Masci, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
TH Open : Companion Journal to Thrombosis and Haemostasis|February 15, 2021
Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease RecurrencePatricia Gomez-Rosas, Marina Pesenti, Cristina Verzeroli, et al.
Cancers|September 23, 2022
Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal CancerCinzia Giaccherini, Cristina Verzeroli, Laura Russo, et al.
Breast Cancer Research and Treatment|September 15, 2016
Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2Irene Catucci, Silvia Casadei, Yuan Chun Ding, et al.
Haematologica|September 28, 2019
Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancerCinzia Giaccherini, Marina Marchetti, Giovanna Masci, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 22, 2014
PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of BergamoIrene Catucci, Paolo Peterlongo, Sara Ciceri, et al.
Journal of Thrombosis and Haemostasis : JTH|March 8, 2025
Activated factor XI-antithrombin and thrombin-antithrombin complexes in the prediction of venous thromboembolism and mortality in patients with non-small-cell lung cancerPatricia Gomez-Rosas, Magdolna Nagy, Henry M H Spronk, et al.
Journal of Thrombosis and Haemostasis : JTH|April 13, 2023
Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohortCristina Verzeroli, Cinzia Giaccherini, Laura Russo, et al.
Cancers|September 28, 2023
A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer PatientsPatricia Gomez-Rosas, Cinzia Giaccherini, Laura Russo, et al.
Hemasphere|August 29, 2025
Prevention and treatment of venous thromboembolism in patients with multiple myeloma: Clinical practice guidelines on behalf of the European Myeloma NetworkGrigoris Gerotziafas, Despina Fotiou, Inger Nijhof, et al.
Journal of Thrombosis and Haemostasis : JTH|May 13, 2020
Thrombin generation predicts early recurrence in breast cancer patientsMarina Marchetti, Cinzia Giaccherini, Giovanna Masci, et al.
Pageof 9